Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2022-08-15 Interim / Quarterly Rep…
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Avicanna Reports Q2 2022 Financial Statement' and discusses financial results for the three-month period ending June 30, 2022, which corresponds to a quarterly period. It includes detailed financial highlights such as revenue figures, cost reductions, licensing agreements, and strategic private placements. The document also contains management commentary on business progress and operational challenges during the quarter. The length of the document (11,496 characters) and the presence of substantive financial data and analysis indicate this is a comprehensive interim financial report rather than a brief announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q2 2022
2022-08-15 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109F1 Certification of Quarterly Filings by the Interim CFO, certifying the review and fair presentation of quarterly financial statements and MD&A for the three-month period ended June 30, 2022. It is primarily an officer certification letter confirming the accuracy and completeness of the quarterly filings, including internal controls and disclosure controls. There are no actual financial statements or substantive financial data presented in this document itself; it is a certification related to the quarterly report. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the quarterly report (IR) itself.
2022-08-15 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F1 Certification of Quarterly Filings by the CEO of Avicanna Inc. It certifies the review and fair presentation of quarterly financial statements and MD&A for the three-month period ended March 31, 2022. The content is primarily an officer certification regarding the quarterly filings, internal controls, and disclosure controls. It does not contain the actual financial statements or substantive financial data but rather attests to their accuracy and completeness. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the quarterly report itself (IR). The document length is 4827 characters, which is relatively short and consistent with a certification letter rather than a full report.
2022-08-15 English
Form of proxy - English.PDF
Regulatory Filings
2022-08-10 English
News release - English.pdf
Regulatory Filings
2022-07-20 English
News release - English.pdf
Regulatory Filings
2022-07-11 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.